A. Pranger

Therapeutic drug monitoring: how to improve moxifloxacin exposure in tuberculosis patients

A. Pranger, 2018 .

Fluoroquinolones, the cornerstone of treatment of drug-resistant tuberculosis: a pharmacokinetic and pharmacodynamic approach.

R. Aarnoutse, J. Alffenaar, A. Pranger, 2011, Current pharmaceutical design.

The Role of Fluoroquinolones in the Treatment of Tuberculosis in 2019

J. Kosterink, J. Alffenaar, T. S. van der Werf, 2019, Drugs.

[Fatal intoxication with nicotine for e-cigarette].

J. Maring, E. Wilms, A. Pranger, 2017, Nederlands tijdschrift voor geneeskunde.